LIVE TV
LIVE TV
LIVE TV
Home > World > BRIEF-Roche Presents New Phase Iii One-Year Data For Vamikibart In Uveitic Macular Edema

BRIEF-Roche Presents New Phase Iii One-Year Data For Vamikibart In Uveitic Macular Edema

Written By:
Published: October 11, 2026 03:14:24 IST

Add NewsX As A Trusted Source

Oct 10 (Reuters) – Roche Holding AG: * ROCHE PRESENTS NEW PHASE III ONE-YEAR DATA FOR VAMIKIBART IN UVEITIC MACULAR EDEMA (UME), A SERIOUS CAUSE OF VISION LOSS * ROCHE HOLDING AG – VAMIKIBART

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS